Star Combo Pharma Ltd.'s market cap is currently AU$24.98M. The company's EPS TTM is AU$0.005; its P/E ratio is 33.64; and it has a dividend yield of 2.00%. Star Combo Pharma Ltd. is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	AU$ 26.02M	AU$ 24.70M	AU$ 22.88M	AU$ 26.72M	AU$ 38.84M
Gross Profit	AU$ 5.44M	AU$ 7.16M	AU$ 5.61M	AU$ 4.61M	AU$ 5.29M
Operating Income	AU$ 723.43K	AU$ 1.14M	AU$ 549.23K	AU$ -889.82K	AU$ -512.54K
EBITDA	AU$ 2.79M	AU$ -2.53M	AU$ -126.71K	AU$ -6.40M	AU$ 352.23K
Net Income	AU$ 747.33K	AU$ -4.00M	AU$ -696.35K	AU$ -7.88M	AU$ -348.69K
Balance Sheet
Cash & Short-Term Investments	AU$ 7.36M	AU$ 9.49M	AU$ 10.39M	AU$ 17.32M	AU$ 26.60M
Total Assets	AU$ 42.82M	AU$ 42.23M	AU$ 43.44M	AU$ 43.32M	AU$ 54.72M
Total Debt	AU$ 4.03M	AU$ 4.19M	AU$ 4.12M	AU$ 3.30M	AU$ 5.61M
Net Debt	AU$ 1.86M	AU$ -5.30M	AU$ -6.27M	AU$ -14.03M	AU$ -20.99M
Total Liabilities	AU$ 9.30M	AU$ 8.97M	AU$ 8.04M	AU$ 7.13M	AU$ 10.22M
Stockholders' Equity	AU$ 33.32M	AU$ 33.09M	AU$ 35.41M	AU$ 36.19M	AU$ 44.50M
Cash Flow
Free Cash Flow	AU$ -1.76M	AU$ -851.83K	AU$ -7.21M	AU$ -6.93M	AU$ -3.80M
Operating Cash Flow	AU$ -316.45K	AU$ 1.88M	AU$ 87.11K	AU$ 331.53K	AU$ -1.02M
Investing Cash Flow	AU$ -136.79K	AU$ -3.23M	AU$ -3.24M	AU$ -7.53M	AU$ -3.63M
Financing Cash Flow	AU$ -370.93K	AU$ -53.44K	AU$ -169.08K	AU$ -2.08M	AU$ 26.63M

Currency in AUD

Star Combo Pharma Ltd. Earnings and Revenue History

Income Statement >

Star Combo Pharma Ltd. Debt to Assets

Balance Sheet >

Star Combo Pharma Ltd. Cash Flow

Cash Flow >

Star Combo Pharma Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing